These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 39142248)

  • 1. Emerging role of BMPs/BMPR2 signaling pathway in treatment for pulmonary fibrosis.
    Ye Q; Taleb SJ; Zhao J; Zhao Y
    Biomed Pharmacother; 2024 Sep; 178():117178. PubMed ID: 39142248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular-Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.
    Yanagihara T; Tsubouchi K; Zhou Q; Chong M; Otsubo K; Isshiki T; Schupp JC; Sato S; Scallan C; Upagupta C; Revill S; Ayoub A; Chong SG; Dvorkin-Gheva A; Kaminski N; Tikkanen J; Keshavjee S; Paré G; Guignabert C; Ask K; Kolb MRJ
    Am J Respir Crit Care Med; 2023 Jun; 207(11):1498-1514. PubMed ID: 36917778
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrophage bone morphogenic protein receptor 2 depletion in idiopathic pulmonary fibrosis and Group III pulmonary hypertension.
    Chen NY; D Collum S; Luo F; Weng T; Le TT; M Hernandez A; Philip K; Molina JG; Garcia-Morales LJ; Cao Y; Ko TC; Amione-Guerra J; Al-Jabbari O; Bunge RR; Youker K; Bruckner BA; Hamid R; Davies J; Sinha N; Karmouty-Quintana H
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L238-54. PubMed ID: 27317687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
    Happé C; Kurakula K; Sun XQ; da Silva Goncalves Bos D; Rol N; Guignabert C; Tu L; Schalij I; Wiesmeijer KC; Tura-Ceide O; Vonk Noordegraaf A; de Man FS; Bogaard HJ; Goumans MJ
    Cells; 2020 Jun; 9(6):. PubMed ID: 32521690
    [No Abstract]   [Full Text] [Related]  

  • 5. Overexpression of bone morphogenetic protein receptor type 2 suppresses transforming growth factor β-induced profibrotic responses in lung fibroblasts.
    Fukihara J; Maiolo S; Kovac J; Sakamoto K; Wakahara K; Hashimoto N; Reynolds PN
    Exp Lung Res; 2022 Feb; 48(1):35-51. PubMed ID: 35037801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis.
    Myllärniemi M; Lindholm P; Ryynänen MJ; Kliment CR; Salmenkivi K; Keski-Oja J; Kinnula VL; Oury TD; Koli K
    Am J Respir Crit Care Med; 2008 Feb; 177(3):321-9. PubMed ID: 17975199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of myofibroblast dedifferentiation in pulmonary fibrosis.
    Ju X; Wang K; Wang C; Zeng C; Wang Y; Yu J
    Respir Res; 2024 Jul; 25(1):284. PubMed ID: 39026235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual inhibition of α
    Decaris ML; Schaub JR; Chen C; Cha J; Lee GG; Rexhepaj M; Ho SS; Rao V; Marlow MM; Kotak P; Budi EH; Hooi L; Wu J; Fridlib M; Martin SP; Huang S; Chen M; Muñoz M; Hom TF; Wolters PJ; Desai TJ; Rock F; Leftheris K; Morgans DJ; Lepist EI; Andre P; Lefebvre EA; Turner SM
    Respir Res; 2021 Oct; 22(1):265. PubMed ID: 34666752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mimosa pudica L. extract ameliorates pulmonary fibrosis via modulation of MAPK signaling pathways and FOXO3 stabilization.
    Nguyen QC; Nguyen HA; Pham TA; Tran VT; Nguyen TD; Pham DV
    J Ethnopharmacol; 2024 Aug; 330():118226. PubMed ID: 38670401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis.
    Vittal R; Mickler EA; Fisher AJ; Zhang C; Rothhaar K; Gu H; Brown KM; Emtiazjoo A; Lott JM; Frye SB; Smith GN; Sandusky GE; Cummings OW; Wilkes DS
    PLoS One; 2013; 8(10):e76451. PubMed ID: 24204629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP7 Promotes TGF-β1 Signaling by De-Ubiquitinating Smad2/Smad3 in Pulmonary Fibrosis.
    Tang F; Gong H; Ke T; Yang W; Yang Y; Liu Z
    Discov Med; 2024 Aug; 36(187):1616-1626. PubMed ID: 39190377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance linked to functional defects in bone morphogenetic protein type 2 receptor, BMPR2.
    Kim MJ; Park SY; Chang HR; Jung EY; Munkhjargal A; Lim JS; Lee MS; Kim Y
    BMB Rep; 2017 Jun; 50(6):308-317. PubMed ID: 28391780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between BMP signaling and KCNK3 in phenotypic switching of pulmonary vascular smooth muscle cells.
    Yeo Y; Jeong H; Kim M; Choi Y; Kim KL; Suh W
    BMB Rep; 2022 Nov; 55(11):565-570. PubMed ID: 36016502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trapping of BMP receptors in distinct membrane domains inhibits their function in pulmonary arterial hypertension.
    Jiang Y; Nohe A; Bragdon B; Tian C; Rudarakanchana N; Morrell NW; Petersen NO
    Am J Physiol Lung Cell Mol Physiol; 2011 Aug; 301(2):L218-27. PubMed ID: 21622843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micro-CT-assisted identification of the optimal time-window for antifibrotic treatment in a bleomycin mouse model of long-lasting pulmonary fibrosis.
    Buccardi M; Grandi A; Ferrini E; Buseghin D; Villetti G; Civelli M; Sverzellati N; Aliverti A; Pennati F; Stellari FF
    Sci Rep; 2024 Jun; 14(1):14792. PubMed ID: 38926490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein signaling protects against cerulein-induced pancreatic fibrosis.
    Gao X; Cao Y; Staloch DA; Gonzales MA; Aronson JF; Chao C; Hellmich MR; Ko TC
    PLoS One; 2014; 9(2):e89114. PubMed ID: 24586530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
    Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of bone morphogenetic protein type II receptor leads to decreased aquaporin 1 expression and function in human pulmonary microvascular endothelial cells.
    Vassiliou AG; Keskinidou C; Kotanidou A; Frantzeskaki F; Dimopoulou I; Langleben D; Orfanos SE
    Can J Physiol Pharmacol; 2020 Nov; 98(11):834-839. PubMed ID: 32687728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.